Visual function linked to preBCVA in AMD cataract patients

Article

Visual function improves in eyes with age-related macular degeneration (AMD) that have undergone cataract surgery, but the extent of the improvement depends on the eye’s preoperative best-corrected visual acuity (preBCVA), according to a new retrospective analysis published in Investigative Ophthalmology and Visual Science.

Visual function improves in eyes with age-related macular degeneration (AMD) that have undergone cataract surgery, but the extent of the improvement depends on the eye’s preoperative best-corrected visual acuity (preBCVA), according to a new retrospective analysis published in Investigative Ophthalmology and Visual Science.

Related: Radiotherapy system receives CE mark extension

The US investigators studied 4,924 cataract surgeries on eyes with AMD for which preoperative and postoperative NEI-VFQ-25 questionnaires had been submitted. All were from the VA Ophthalmic Surgical Outcomes Data Project. The researchers compared outcomes in these eyes with outcomes in control eyes that did not have retinal pathology, looking at changes in visual acuity and improvement in overall visual function and its subscales.

Analysing overall scores, the investigators found that, for eyes with a preBCVA of ≥20/40, the improvement in visual function was similar to that seen in patients without retinal pathology. If the eye’s preBCVA was <20/40, however, then there was a lesser degree of improvement; the amount of improvement decreased with decreasing preBCVA. 

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.